Cargando…
Lupus : symptoms, treatment and potential complications /
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
New York :
Nova Science Publishers,
©2012.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- LUPUS: SYMPTOMS, TREATMENT AND POTENTIAL COMPLICATIONS; LUPUS: SYMPTOMS, TREATMENT AND POTENTIAL COMPLICATIONS; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Chapter I: Lupus Erythematosus: A Comprehensive Review; Abstract; Abbreviations; Defining Lupus; Lupus Incidence and Prevalence; Causes of Lupus; Diagnosing Lupus; Autoantibodies in Lupus; Lupus Blood Tests; Urine Testing; Other Tests; Pregnancy and Contraception for Women with Lupus; Current Research in Lupus; Genetics in Lupus; Biomarkers; The Disease Process; Lupus and the Skin, Hair and Mucosae.
- Lupus and the SunLupus and the Musculoskeletal System; Podiatric Care in Lupus; Lupus and the Mucosae; Mixed Connective Tissue Disease, or Overlap Syndrome; Differential Diagnoses of Lupus; Coping with Lupus among Family and Friends; Treatment; NSAIDs; Antimalarials; Corticosteroids; Immunosuppressives; BLyS-Specific Inhibitors; Other Lupus Therapies; Alternative and Complementary Therapies; References; Chapter II: Autoantibody-Producing B Cellsand B Cell Therapy in Systemic Lupus Erythematosus
- Possible New Targets of Novel Subsets of RP105-NegativeB Cells; Abstract; Introduction.
- Section 1. B Cell Biology in SLESection 2. Therapies of Targeting B Cells in SLE; Conclusion; Reference; Chapter III: Neuropsychiatric Manifestations in Systemic Lupus Erythematosus; Abstract; Introduction; Classification Criteria; NPSLE Epidemiology; Clinical Relevance; Risk Factors for NPSLE; Pathophysiology; Diagnosis; Clinical and Laboratory Investigation; Therapeutic Strategies in NPSLE; Conclusion; Acknowledgments; References; Chapter IV: Treatment in Systemic Lupus Erythematosus; Abstract; Introduction; Conventional Therapies; B-Cell Targeting.
- T-Cell Targeting and Co-Stimulatory BlockadeAnticytokines Therapy; Complement Inhibition; Conclusion; Acknowledgments; References; Chapter V: Hematologic Manifestations of Systemic Lupus Erythematosus; Anemia; Leukopenia; Lymphopenia; Neutropenia; Thrombocytopenia; Bone Marrow as a Target Organ in SLE; Hematological Manifestations, SLE Subsets and Prognosis; References; Chapter VI: Interleukin-21 in Systemic Lupus Erythematosus: Pathogenic Relevance and Therapeutic Applications; Abstract; Introduction: Overview on Systemic Lupus Erythematosus; Multiple Roles for B Cells in SLE.
- IL-21 Is aCritical Regulator of B Cell ResponsesIL-21 and SLE; Treatment of Spontaneous Lupus Mice Using Agents Able to Block IL-21/IL-21R Signaling; Conclusion; References; Chapter VII: Metabolic Syndrome and Inflammatory Cytokines in Systemic Lupus Erythematosus; Abstract; Introduction; CVD in SLE; Traditional Risk Factors; Non-Traditional Risk Factors; CVD Features and Cytokines Involved on SLE; Relationship between SLE Treatment in Patients with MetS; What Is the Best Treatment to MetS in SLE Patients?; Conclusion and Perspective Future; Acknowledgments; References.